A-80915 C
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Antibiotics |
Catalog number | BBF-03169 |
CAS | 127875-62-1 |
Molecular Weight | 547.89 |
Molecular Formula | C26H33Cl3O6 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
A-80915 C is a naphthoquinone antibiotic produced by Streptomyces aculeolatus A80915. Activity against gram-positive bacteria.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | 3,4a-dichloro-10a-(3-chloro-6-hydroxy-2,2,6-trimethyl-cyclohexylmethyl)-6,8-dihydroxy-2,2,7-trimethyl-3,4,4a,10a-tetrahydro-2H-benzo[g]chromene-5,10-dione |
IUPAC Name | (3R,4aR,10aS)-3,4a-dichloro-10a-[[(1S,3S,6S)-3-chloro-6-hydroxy-2,2,6-trimethylcyclohexyl]methyl]-6,8-dihydroxy-2,2,7-trimethyl-3,4-dihydrobenzo[g]chromene-5,10-dione |
Canonical SMILES | CC1=C(C=C2C(=C1O)C(=O)C3(CC(C(OC3(C2=O)CC4C(C(CCC4(C)O)Cl)(C)C)(C)C)Cl)Cl)O |
InChI | InChI=1S/C26H33Cl3O6/c1-12-14(30)9-13-18(19(12)31)21(33)25(29)11-17(28)23(4,5)35-26(25,20(13)32)10-15-22(2,3)16(27)7-8-24(15,6)34/h9,15-17,30-31,34H,7-8,10-11H2,1-6H3/t15-,16-,17+,24-,25-,26-/m0/s1 |
InChI Key | XGGIVXWAYKZBIV-CYGDAPSSSA-N |
Appearance | Yellow Crystal |
Antibiotic Activity Spectrum | Gram-positive bacteria |
Density | 1.32 g/cm3 |
BBF-03784 | Lipstatin | Inquiry |
BBF-03862 | Cefozopran hydrochloride | Inquiry |
BBF-03473 | Wortmannin | Inquiry |
BBF-04727 | Strigolactone GR24 | Inquiry |
BBF-03428 | Tubermycin B | Inquiry |
BBF-03753 | Baicalin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
